Co-accumulation of vascular endothelial growth factor with β-amyloid in the brain of patients with Alzheimer's disease

Neurobiology of Aging

Volumn 25, Issue 3, 2004, Pages 283-290

  Yang, Seung Pil ^a   Bae, Dong Goo ^a   Kang, Hyo Jung ^b   Gwag, Byoung Joo ^b   Gho, Yong Song ^c   Chae, Chi Bom ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Alzheimer's disease; Hypoperfusion; Senile plaque; Vascular endothelial growth factor; amyloid

Indexed keywords

AMYLOID BETA PROTEIN; VASCULOTROPIN;

ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; BRAIN; BRAIN PERFUSION; CONTROLLED STUDY; EXPERIMENT; HUMAN; HUMAN TISSUE; IN VITRO STUDY; PATIENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN LOCALIZATION; SENILE PLAQUE;

EID: 1242338809     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00111-8     Document Type: Article

References (45)

1. Bae D.G., Gho Y.S., Yoon W.H., Chae C.B. Arginine-rich anti-vascular endothelial growth factor peptides inhibit tumor growth and metastasis by blocking angiogenesis. J. Biol. Chem. 275(18):2000;13588-13596.
2. Bennett S.A., Pappas B.A., Stevens W.D., Davidson C.M., Fortin T., Chen J. Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion. Neurobiol. Aging. 21(2):2000;207-214.
3. Bohrmann B., Tjernberg L., Kuner P., Poli S., Levet-Trafit B., Naslund J.et al. Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 274(23):1999;15955-15990.
4. Chang P., Su Y. Protocol for qualitative analysis of the in vitro aggregation of synthetic beta-amyloid: a method applicable to the identification of substances that may have therapeutic efficacy for Alzheimer's disease. Brain Res. Brain Res. Protoc. 6(1/2):2000;6-12.
5. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke. 33(4):2002;1152-1162.
6. de Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255(5047):1992;989-991.
7. DeBlasi A., O'Reilly K., Motulsky H.J. Calculating receptor number from binding experiments using same compound as radioligand and competitor. Trends Pharmacol. Sci. 10(6):1989;227-229.
8. Ferrara N. Role of vascular endothelial growth factor in regulation of physiological angiogenesis. Am. J. Physiol. Cell Physiol. 280(6):2001;1358-1366.
9. Gitay-Goren H., Soker S., Vlodavsky I., Neufeld G. The binding of vascular endothelial growth factor to its receptor is dependent on cell surface-associated heparin-like molecules. J. Biol. Chem. 267(9):1992;6093-6098.
10. Guo Q., Sebastian L., Sopher B.L., Miller M.W., Glazner G.W., Ware C.B. et al. Neurotrophic factors [activity-dependent neurotrophic factor (ADNF) and basic fibroblast growth factor (bFGF)] interrupt excitotoxic neurodegenerative cascades promoted by a PS1 mutation. Proc. Natl. Acad. Sci. U.S.A. 96(7):1999;4125-4130.
11. Hamazaki H. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. J. Biol. Chem. 270(18):1995;10392-10394.
12. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297(5580):2002;353- 356.
13. Harrigan M.R., Ennis S.R., Masada T., Keep R.F. Intraventricular infusion of vascular endothelial growth factor promotes cerebral angiogenesis with minimal brain edema. Neurosurgery. 50(3):2002;589-598.
14. Hughes S.R., Khorkova O., Goyal S., Knaeblein J., Heroux J., Riedel N.G.et al. Alpha2-macroglobulin associates with beta-amyloid peptide and prevents fibril formation. Proc. Natl. Acad. Sci. U.S.A. 95(6):1998;3275-3280.
15. Jendroska K., Poewe W., Daniel S.E., Pluess J., Iwerssen-Schmidt H., Paulsen J.et al. Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol. (Berl.). 90(5):1995;461-466.
16. Jin K.L., Mao X.O., Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. U.S.A. 97(18):2000;10242-10247.
17. Kalaria R.N. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging. 21(2):2000;321-330.
18. Kalaria R.N., Cohen D.L., Premkumar D.R.D., Nag S., LaManna J.C., Lust W.D. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Mol. Brain Res. 62(1):1998;101-105.
19. Kokmen E., Whisnant J.P., O'Fallon W.M., Chu C.-P., Beard C.M. Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960-1984). Neurology. 46(1):1996;154-159.
20. Marti H.H., Risau W. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors. Proc. Natl. Acad. Sci. U.S.A. 95(26):1998;15809-15814.
21. Marti H.J., Bernaudin M., Bellail A., Schoch H., Euler M., Petit W.et al. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am. J. Pathol. 156(3):2000;965-976.
22. Matsuzaki H., Tamatani M., Yamaguchi A., Namikawa K., Kiyama H., Vitek M.P.et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: signal transduction cascades. FASEB J. 15(7):2001;1218-1220.
23. Mudher A., Lovestone S. Alzheimer's disease - do tauists and baptists finally shake hands? Trends Neurosci. 25(1):2002;22-26.
24. Ogunshola O.O., Antic A., Donoghue M.J., Fan S.Y., Kim H., Stewart W.B. et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J. Biol. Chem. 277(13):2002;11410-11415.
25. Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K.et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 28(2):2001;131-138.
26. Schratzberger P., Schratzberger G., Silver M., Curry C., Kearney M., Magner M.et al. Favorable effect of Vegf gene transfer on ischemic peripheral neuropathy. Nat. Med. 6(4):2000;405-413.
27. Siegel G.J., Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 33(2/3):2000;199-227.
28. Snow A.D., Sekiguchi R.T., Nochlin D., Kalaria R.N., Kimata K. Heparan sulfate proteoglycan in diffuse plaques of hippocampus but not in cerebellum of Alzheimer's disease. Am. J. Pathol. 144:1994;337-347.
29. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA. 277(10):1997;813-817.
30. Soker S., Takashima S., Miao H.Q., Neufeld G., Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell. 92(6):1998;735-745.
31. Sommer B. Alzheimer's disease and the amyloid cascade hypothesis: ten years on. Curr. Opin. Pharmacol. 2(1):2002;87-92.
32. Sondell M., Lundborg G., Kanje M. Vascular endothelial growth factor has neurotropic activity and stimulates axonal growth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci. 19(14):1999;5731-5740.
33. Stein I., Neeman M., Shweiki D., Itin A., Keshet E. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Mol. Cell Biol. 15(10):1995;5363-5368.
34. Strittmatter W.J., Weisgraber K.H., Huang D.Y., Dong L., Salvesen G.S., Pericak-Vance M.et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90(17):1993;8098-8102.
35. Su Y., Chang P.T. Acidic pH promotes the formation of toxic fibrils from beta-amyloid peptide. Brain Res. 893(1/2):2001;287-291.
36. Tarkowski E., Issa R., Sjogren M., Wallin A., Blennow K., Tarkowski A.et al. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging. 23(2):2002;237-243.
37. Terman B.I., Dougher-Vermazan M., Carrion M.E., Dimitrov D., Armellino D.C., Gospodarowicz D.et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun. 187(3):1992;1579-1586.
38. Thomas K.A. Vascular endothelial growth factor, a potent and selective angiogenic factor. J. Biol. Chem. 271(2):1996;603-606.
39. Thomas T., Thomas G., McLendon C., Sutton T., Mullan M. Beta-amyloid-mediated vasoactivity and vascular endothelial damage. Nature. 380(6570):1996;168-171.
40. Vassar R., Citron M. A beta-generating enzymes: recent advances in beta- and gamma-secretase research. Neuron. 27(3):2000;419-422.
41. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology. 20(1):2000;8-22.
42. Yankner B.A. Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron. 16(5):1996;921-932.
43. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S., Wiegand S.J., Holash J. Vascular-specific growth factors and blood vessel formation. Nature. 407(6801):2000;242-248.
44. Yates C.M., Butterworth J., Tennant M.C., Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55(5):1990;1624-1630.
45. Zhang Z.G., Zhang L., Jiang Q., Zhang R., Davies K., Powers C.et al. VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106(7):2000;829-838.